DEXCOM INC (DXCM)
@DXCM.asset
$81.62
At close:
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Figures
- Sector Healthcare
- Industry Medical Diagnostics & Research
- Index Nasdaq-100, S&P 500
- Market Cap $32.00 B
- Last Earnings Report May 1, 2025
- Price Reaction to Earnings Report 9.01%
- Enterprise Value $31.77 B
- P/E ratio 60.06
- Price/Sales ratio 7.75
- EV/Sales ratio 7.66
- Price/Book Value 14.18
- Revenue $4.15 B
- EBIT $0.00 B
- Net Income $0.54 B
- Gross Profit $2.47 B
- Free Cash Flow $0.58 B
- EBIT Margin ?%
- Gross Margin 59.43%
- FCF Margin 13.87%
- Return on Equity 23.61%
- Equity Ratio 33.57%
- Debt/Equity Ratio 1.98
- 6-month Performance 16.02%
- 12-month Performance -35.55%
- Trend reversal good
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |